The estimated Net Worth of Randy S. Saluck is at least $19.4 Tisíc dollars as of 25 February 2015. Mr. Saluck owns over 1,891 units of Cytocom Inc stock worth over $19,388 and over the last 11 years he sold CBLI stock worth over $0. In addition, he makes $0 as Independent Director at Cytocom Inc.
Sign up
Mr. Saluck CBLI stock SEC Form 4 insiders trading
Randy has made over 2 trades of the Cytocom Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 1,891 units of CBLI stock worth $6,467 on 25 February 2015.
The largest trade he's ever made was buying 3,500 units of Cytocom Inc stock on 17 May 2013 worth over $5,600. On average, Randy trades about 1,078 units every 130 days since 2013. As of 25 February 2015 he still owns at least 6,116 units of Cytocom Inc stock.
You can see the complete history of Mr. Saluck stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Randy Saluck biography
Randy S. Saluck J.D. serves as Independent Director of the Company. Mr. Saluck previously served as one of our directors from May 2013 until April 2016 and was subsequently reappointed to the Board in July 2016 to fill a vacancy. Since 2017, Mr. Saluck has been the Chief Executive Officer and a Director of Libertas Funding LLC, a company focused on providing funding for small businesses. Since 2015, Mr. Saluck has been part-time Chief Financial Officer and General Counsel of Convexity Scientific, LLC., a private medical device company on whose board he served from February 2016 to October 2017 as a director. From 2005 to 2017, Mr. Saluck was the Managing Member of Mortar Rock Capital Management, LLC and the Portfolio Manager of Mortar Rock Capital LP, a value-oriented investment fund. Since 2014, Mr. Saluck has served as the Chief Strategic Officer of Accelerated Pharma, Inc., a company focused on genomic technology to develop drugs for oncology and other indications. From 2002 to 2005, Mr. Saluck was a portfolio manager at the investment fund of Meisenbach Capital, LP and, from 2000 to 2002, Mr. Saluck was a senior analyst at Tyndall Partners, LLC, which invested in value-oriented equities and distressed debt. From 1999 to 2000, Mr. Saluck was an analyst at Highfields Capital Management, LLC, where he was responsible for special situations and risk arbitrage. Prior thereto, Mr. Saluck was an investment banker focused on mergers and acquisitions involving a variety of industries at Salomon Brothers Inc. Before becoming an investment banker, Mr. Saluck was a corporate and securities attorney, working at Cahill Gordon & Reindel LLP and then Tenzer Greenblatt LLP. As an attorney, Mr. Saluck worked with numerous small capitalization companies assisting them in the execution of their financing and strategic plans. He received a Bachelor’s degree from the University of Pennsylvania, a Juris Doctor degree from the University of Virginia and an MBA from the Wharton School of the University of Pennsylvania with a
How old is Randy Saluck?
Randy Saluck is 55, he's been the Independent Director of Cytocom Inc since 2013. There are 2 older and 6 younger executives at Cytocom Inc. The oldest executive at Cytocom Inc is Langdon Miller, 66, who is the President, Chief Medical Officer.
What's Randy Saluck's mailing address?
Randy's mailing address filed with the SEC is C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO, NY, 14203.
Insiders trading at Cytocom Inc
Over the last 17 years, insiders at Cytocom Inc have traded over $1,157,190 worth of Cytocom Inc stock and bought 66,403 units worth $199,902 . The most active insiders traders include James Antal, Michael Fonstein a Bernard L Kasten. On average, Cytocom Inc executives and independent directors trade stock every 101 days with the average trade being worth of $21,921. The most recent stock trade was executed by Langdon L Miller on 22 July 2021, trading 10,000 units of CBLI stock currently worth $30,000.
What does Cytocom Inc's logo look like?
Complete history of Mr. Saluck stock trades at Cytocom Inc
Cytocom Inc executives and stock owners
Cytocom Inc executives and other stock owners filed with the SEC include:
-
Christopher Zosh,
Interim Principal Executive Officer and Principal Financial Officer, Vice President of Finance -
Langdon Miller,
President, Chief Medical Officer -
Andrei Gudkov,
Chief Scientific Officer -
Lea Verny,
Independent Chairman of the Board -
Daniil Talyanskiy,
Independent Director -
Randy Saluck,
Independent Director -
Anna Evdokimova,
Independent Director -
Alexander Andryushechkin,
Independent Director -
Ivan Fedyunin,
Independent Director -
Anthony Principi,
Director -
C Neil Lyons,
Chief Financial Officer -
Elena Kasimova,
Director -
Yakov Kogan,
EVP of Bus. Development, Sec. -
Richard Mc Gowan,
Director -
James Antal,
Director -
Daniel Floyd Jr Hoth,
Director -
Julia R Brown,
Director -
Alexander Polinsky,
Director -
David C Hohn,
Director -
Bernard L Kasten,
Director -
Jean Viallet,
Chief Development Officer -
Paul E Di Corleto,
Director -
Michael Fonstein,
CEO & President -
Hector Daniel Perez,
Director -
John A Jr Marhofer,
Chief Financial Officer -
Securities Corp Sunrise,
10% owner -
Michael K Handley,
President and CEO -
Robert Buckheit,
Chief Technology Officer -
Cozette M. Mc Avoy,
Chief Legal Officer -
Clifford Selsky,
Chief Medical Officer -
Peter Aronstam,
Chief Financial Officer